Literature DB >> 8520880

Prophylaxis of streptococcal bacteraemia with oral penicillin V in children undergoing bone marrow transplantation.

E Castagnola1, E Lanino, A Garaventa, G Dini, S Dallorso, G Carrega, C Viscoli.   

Abstract

The work described aimed to evaluate the incidence of streptococcal bacteraemia in children undergoing bone marrow transplantation and receiving prophylaxis with penicillin V. From January 1991 to December 1993 oral penicillin V was administered as prophylaxis for streptococcal bacteraemia to patients undergoing bone marrow transplantation at G. Gaslini Children's Hospital, Genoa, Italy. The data were compared with those from a similar population receiving bone marrow transplantation from September 1984 to July 1990 and not receiving this kind of prophylaxis. Streptococcal bacteraemia was diagnosed in 7/17 (41%) episodes of bacteraemia observed in the period January 1991 to December 1993, while it accounted for 71% of all bacteraemias in the period from September 1984 to July 1990 and was especially frequent from January 1988 to July 1990, comprising 13/15 (87%) of observed bacteremias. The decrease of this complication observed after the beginning of the prophylaxis programme was statistically significant. Oral penicillin V is effective as prophylaxis of streptococcal bacteraemias in children receiving bone marrow transplantation in a centre with a high incidence of this complication.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8520880     DOI: 10.1007/bf00335310

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  11 in total

1.  Early infectious complications in children undergoing BMT.

Authors:  C Viscoli; E Castagnola; C Moroni; L Boni; S Dallorso; A Garaventa; E Lanino; G Dini
Journal:  Bone Marrow Transplant       Date:  1991       Impact factor: 5.483

2.  A long-term prospective clinical study of oral complications during conventional chemotherapy for acute leukemia.

Authors:  A P Barrett
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1987-03

Review 3.  Emerging antimicrobial resistance and the immunocompromised host.

Authors:  D M Shlaes; B Binczewski; L B Rice
Journal:  Clin Infect Dis       Date:  1993-11       Impact factor: 9.079

4.  Streptococcal and enterococcal bacteremia in patients with cancer.

Authors:  A Awada; P van der Auwera; F Meunier; D Daneau; J Klastersky
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

5.  Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors.

Authors:  L S Elting; G P Bodey; B H Keefe
Journal:  Clin Infect Dis       Date:  1992-06       Impact factor: 9.079

6.  Evaluation of penicillin G in the prevention of streptococcal septicaemia in patients with acute myeloid leukaemia undergoing cytotoxic chemotherapy.

Authors:  P de Jong; M de Jong; E Kuijper; J van der Lelie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

7.  Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases.

Authors:  W Kern; E Kurrle; T Schmeiser
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

8.  Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.

Authors:  P Y Bochud; P Eggiman; T Calandra; G Van Melle; L Saghafi; P Francioli
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

9.  Reduction of fever and streptococcal bacteremia in granulocytopenic patients with cancer. A trial of oral penicillin V or placebo combined with pefloxacin. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.

Authors: 
Journal:  JAMA       Date:  1994-10-19       Impact factor: 56.272

10.  Incidence and clinical epidemiology of streptococcal septicemia during treatment of acute myeloid leukemia.

Authors:  H van der Lelie; R J van Ketel; A E von dem Borne; R H van Oers; B L Thomas; R Goudsmit
Journal:  Scand J Infect Dis       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.